Physician profile
Hassan B Nasser
NPI 1902293129
$8,173.41
in general payments reported to CMS, 2019-2025
10 companies · $3,765 in 2025
The $3,765 reported for 2025 was more than what 94% of Plastic Surgery Within The Head & Neck providers received nationally (typical 2025 total: $238).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $74.06 · 2021: $226 · 2022: $150 · 2023: $932 · 2024: $3,025 · 2025: $3,765.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $6,020 · Food and Beverage: $1,042 · Travel and Lodging: $661.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $6,020.00 |
| Food and Beverage | $1,042.10 |
| Travel and Lodging | $660.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Pharmaceuticals, INC. | $3,505.74 | 2025 | Libtayo |
| Stryker Corporation | $2,786.61 | 2020-2024 | |
| Medical Device Business Services, INC. | $660.59 | 2023 | |
| Inspire Medical Systems, INC. | $561.54 | 2024-2025 | Inspire |
| Acclarent, INC | $265.96 | 2022-2023 | Relieva Spinplus |
| Axogen | $123.14 | 2025 | |
| Regeneron Healthcare Solutions, INC. | $121.83 | 2023 | Dupixent |
| Medtronic, INC. | $113.69 | 2021 | |
| Acera Surgical, INC. | $17.25 | 2023 | Restrata Wound Matrix |
| Aroa Biosurgery Incorporated | $17.06 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hassan Nasser listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.